Deerfield Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Deerfield Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,401,000	Closed	-$136M	–	589
2024 Q1	$136M	Hold	6,401,000	–	–	2.37%	9
2023 Q4	$61.5M	Buy	6,401,000 +3,578,000	+127%	+$17.4M	1.14%	26
2023 Q3	$7.34M	Hold	2,823,000	–	–	0.16%	64
2023 Q2	$13.2M	Hold	2,823,000	–	–	0.28%	62
2023 Q1	$10.6M	Buy	+2,823,000	New	+$11.1M	0.24%	72
2021 Q1	–	Sell	-162,378	Closed	-$1.91M	–	155
2020 Q4	$1.91M	Sell	162,378 -809,668	-83%	-$10.2M	0.04%	126
2020 Q3	$11.7M	Sell	972,046 -284,954	-23%	-$3.89M	0.28%	80
2020 Q2	$22M	Buy	+1,257,000	New	+$21.9M	0.64%	50

Deerfield Management's FUSN Position: Q2 2024 in Review

Deerfield Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 6,401,000 shares — an estimated $136M sold.

Deerfield Management first reported a position in FUSN in Q2 2020 and held it in 8 quarters. The position peaked at $136M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Deerfield Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Deerfield Management sold 6,401,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $136M.
Deerfield Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 8 quarters.
Deerfield Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $136M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.